Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The MiniBox+ has received FDA clearance in the US and regulatory approvals in Canada and Australia. It provides fully automated lung volume measurements and diffusing capacity testing. The system meets American Thoracic Society guidelines for pulmonary function testing and can be used by a wide range of healthcare professionals. Integration with NIOX VERO allows measurement of fractional exhaled nitric oxide for asthma management[5][6].
No clinical trial results are relevant as this is a diagnostic device.
The company has expanded globally with sales in Japan, Brazil, North America, Europe, Australia, and Canada[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PulmOne.